GLOBAL COST EFFECTIVE ANALYSIS OF APIXABAN VERSUS WARFARIN FOR THE PREVENTION OF STROKE AS A RESULT OF ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW

被引：0
|
作者：
Petrenchik, L. [1 ]
Hussain, N. [1 ]
Charles, P. [1 ]
Peprah, H. [1 ]
Loh, F. E. [1 ]
机构：
[1] Touro Coll Pharm, New York, NY USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.372
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV50
引用
收藏
页码：S61 / S61
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF APIXABAN VERSUS STANDARD OF CARE FOR THE PREVENTION OF STROKE: AN ANALYSIS OF PATIENTS WITH ATRIAL FIBRILLATION IN GRECE
    Athanasakis, K.
    Arzoumanidou, D.
    Karampli, E.
    Armelidou, E.
    Giovas, P.
    Petrikkou, E.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2013, 16 (07) : A524 - A525
  • [32] Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin
    Lee, Soyon
    Anglade, Moise W.
    Meng, Joy
    Hagstrom, Kelly
    Kluger, Jeffrey
    Coleman, Craig I.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (04): : 472 - 479
  • [33] Efficacy and safety of apixaban compared with warfarin for stroke prevention in atrial fibrillation in East Asia
    Goto, S.
    Zhu, J.
    Lisheng, L.
    Oh, B. H.
    Wojdyla, D.
    Hanna, M.
    Horowitz, J.
    Wallentin, L.
    Xavier, D.
    Alexander, J. H.
    EUROPEAN HEART JOURNAL, 2013, 34 : 1039 - 1039
  • [34] Apixaban Compared With Warfarin for Stroke Prevention in Atrial Fibrillation Implications of Time in Therapeutic Range
    Gallego, Pilar
    Antonio Vilchez, Juan
    Lane, Deirdre A.
    CIRCULATION, 2013, 127 (22) : 2163 - 2165
  • [35] EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO AGE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
    Halvorsen, S.
    Wallentin, L.
    Yang, H.
    De Caterina, R.
    Erol, C.
    Garcia, D. A.
    Granger, C. B.
    Hanna, M.
    Held, C.
    Husted, S.
    Hylek, E.
    Jansky, P.
    Lopes, R. D.
    Ruzyllo, W.
    Thomas, L.
    Atar, D.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S255 - S255
  • [36] EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO AGE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
    Halvorsen, Sigrun
    Wallentin, Lars
    Yang, Hongqiu
    De Caterina, Raffaele
    Erol, Cetin
    Garcia, David
    Granger, Christopher B.
    Hanna, Michael
    Held, Claes
    Husted, Steen
    Hylek, Elaine
    Jansky, Petr
    Lopes, Renato
    Ruzyllo, Witold
    Thomas, Laine
    Atar, Dan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E315 - E315
  • [37] Is Dabigatran Cost Effective Compared With Warfarin for Stroke Prevention in Atrial Fibrillation? A Critically Appraised Topic
    Adcock, Amelia K.
    Lee-Iannotti, Joyce K.
    Aguilar, Maria I.
    Hoffman-Snyder, Charlene R.
    Wingerchuk, Dean M.
    Wellik, Kay E.
    Demaerschalk, Bart M.
    NEUROLOGIST, 2012, 18 (02) : 102 - 107
  • [38] Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation A Systematic Review and Meta-Analysis
    Proietti, Marco
    Romanazzi, Imma
    Romiti, Giulio Francesco
    Farcomeni, Alessio
    Lip, Gregory Y. H.
    STROKE, 2018, 49 (01) : 98 - +
  • [39] Cost-Effectiveness and Budget Impact Analysis of Apixaban and Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation (NVAF) in Iran
    Tajik, Amirmohammad
    Abbasi, Azam
    Goudarzi, Zahra
    Izadi-Moud, Azadeh
    Varmaghani, Mehdi
    CLINICAL CARDIOLOGY, 2024, 47 (06)
  • [40] Critique of Apixaban Versus Warfarin in Patients With Atrial Fibrillation
    Nedeltchev, Krassen
    STROKE, 2012, 43 (03) : 922 - 923
12345